Get Carter, But This Must Not Be A Missed Opportunity For NHS/Industry Partnerships
This article was originally published in Clinica
The UK medtech industry brands the Carter review and its NHS operating savings aims as “bold and ambitious”. Saving £5bn ($7.4bn) on non-pay NHS costs is the aim by 2020-21, and although that is less than a quarter of the projected funding shortfall that internal efficiency measures are being asked to address, the UK ABHI feels broadly positive about the initiative.
Register for our free email digests: